Get the Stockscreener App
0.9558
0.90%
0.0085
After Hours:
.94
-0.0158
-1.65%
Pds Biotechnology Corporation stock is traded at $0.9558, with a volume of 403.16K.
It is up +0.90% in the last 24 hours and down -17.60% over the past month.
PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.
See More
Previous Close:
$0.9473
Open:
$0.9477
24h Volume:
403.16K
Relative Volume:
0.82
Market Cap:
$44.95M
Revenue:
-
Net Income/Loss:
$-40.56M
P/E Ratio:
-0.8169
EPS:
-1.17
Net Cash Flow:
$-35.28M
1W Performance:
-0.72%
1M Performance:
-17.60%
6M Performance:
-7.20%
1Y Performance:
-72.05%
1-Day Range:
$0.9277
$0.98
1-Week Range:
$0.9277
$1.04
52-Week Range:
$0.8505
$3.48
Pds Biotechnology Corporation Stock (PDSB) Company Profile
Name
Pds Biotechnology Corporation
Sector
Industry
Phone
800-208-3343
Address
303A COLLEGE ROAD EAST, PRINCETON
Compare PDSB with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PDSB
Pds Biotechnology Corporation
|
0.9558 | 44.55M | 0 | -40.56M | -35.28M | -1.17 |
|
VRTX
Vertex Pharmaceuticals Inc
|
407.37 | 104.55B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
464.95 | 60.36B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
557.73 | 59.84B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
799.56 | 49.07B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ONC
Beone Medicines Ltd Adr
|
327.03 | 35.16B | 4.56B | -176.77M | 225.30M | -1.7177 |
Pds Biotechnology Corporation Stock (PDSB) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-01-22 | Initiated | B. Riley Securities | Buy |
| Jun-28-21 | Initiated | Cantor Fitzgerald | Overweight |
| Nov-10-20 | Upgrade | H.C. Wainwright | Neutral → Buy |
| May-27-20 | Initiated | Alliance Global Partners | Buy |
| Mar-09-20 | Initiated | Noble Capital Markets | Outperform |
| Oct-24-19 | Initiated | Chardan Capital Markets | Buy |
View All
Pds Biotechnology Corporation Stock (PDSB) Latest News
Will PDS Biotechnology Corporation stock go up soonQuarterly Profit Report & Technical Entry and Exit Tips - newser.com
Is a relief rally coming for PDS Biotechnology Corporation holdersJuly 2025 Patterns & Fast Moving Trade Plans - newser.com
Will PDS Biotechnology Corporation stock reach all time highs in 2025Earnings Overview Report & AI Powered Trade Plan Recommendations - newser.com
Using data models to predict PDS Biotechnology Corporation stock movement2025 Winners & Losers & Low Risk Investment Opportunities - newser.com
What technical models suggest about PDS Biotechnology Corporation’s comebackTreasury Yields & Daily Oversold Stock Bounce Ideas - newser.com
Automated trading signals detected on PDS Biotechnology CorporationSwing Trade & Real-Time Volume Trigger Notifications - newser.com
Is PDS Biotechnology Corporation showing signs of accumulationTreasury Yields & AI Powered Market Entry Strategies - newser.com
Real time scanner hits for PDS Biotechnology Corporation explained2025 Top Gainers & Technical Pattern Alert System - newser.com
Visualizing PDS Biotechnology Corporation stock with heatmapsLong Setup & Free Growth Oriented Trading Recommendations - newser.com
Why PDS Biotechnology Corporation is moving todayWeekly Profit Report & Consistent Return Strategy Ideas - newser.com
What drives PDS Biotechnology Corporation stock priceEarnings Surprise Analysis & Start Learning With Our Courses - earlytimes.in
How to integrate PDS Biotechnology Corporation into portfolio analysis toolsJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
What’s the recovery path for long term holders of PDS Biotechnology Corporation - newser.com
Momentum divergence signals in PDS Biotechnology Corporation chartQuarterly Profit Report & Community Verified Watchlist Alerts - newser.com
Is PDS Biotechnology Corporation stock undervalued vs historical averagesJuly 2025 Closing Moves & Long-Term Capital Growth Strategies - newser.com
Is PDS Biotechnology Corporation stock a safe investment in uncertain marketsGlobal Markets & Daily Chart Pattern Signal Reports - newser.com
What valuation multiples suggest for PDS Biotechnology Corporation stockWeekly Trend Recap & Free Technical Pattern Based Buy Signals - newser.com
Using data filters to optimize entry into PDS Biotechnology CorporationShare Buyback & Stock Portfolio Risk Management - newser.com
Key resistance and support levels for PDS Biotechnology Corporation2025 Fundamental Recap & Capital Protection Trade Alerts - newser.com
Pds Biotechnology Corporation Stock (PDSB) Financials Data
Revenue
Net Income
Cash Flow
EPS
Pds Biotechnology Corporation Stock (PDSB) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Glover Stephen C. | Director |
Feb 28 '25 |
Buy |
1.66 |
15,061 |
25,001 |
78,851 |
1.11%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):